Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis

Thrombosis Research

Volumn 153, Issue , 2017, Pages 28-36

  Xie, Jinwei ^a   Hu, Qinsheng ^a   Huang, Qiang ^a   Ma, Jun ^a   Lei, Yiting ^a   Pei, Fuxing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Enhanced recovery after surgery; Total hip arthroplasty; Total knee arthroplasty; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLOOD TRANSFUSION; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIMB SWELLING; LUNG EMBOLISM; META ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; WOUND COMPLICATION; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; OPERATIVE BLOOD LOSS; PROCEDURES; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, TOPICAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; TRANEXAMIC ACID;

EID: 85015641017     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2017.03.009     Document Type: Review

References (47)

1. [1] Kurtz, S., Ong, K., Lau, E., Mowat, F., Halpern, M., Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89:4 (2007), 780–785.
2. [2] Kehlet, H., Fast-track hip and knee arthroplasty. Lancet 381:9878 (2013), 1600–1602.
3. [3] Xie, J., Ma, J., Kang, P., et al. Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb. Res. 136:2 (2015), 234–238.
4. [4] Duncan, C.M., Gillette, B.P., Jacob, A.K., et al. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J. Arthroplast. 30:2 (2015), 272–276.
5. [5] Wang, C., Kang, P., Ma, J., et al. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb. Res. 141 (2016), 119–123.
6. [6] Alshryda, S., Sarda, P., Sukeik, M., et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J. Bone Joint Surg. (Br.) 93:12 (2011), 1577–1585.
7. [7] Yue, C., Kang, P., Yang, P., et al. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J. Arthroplast. 29:12 (2014), 2452–2456.
8. [8] Alshryda, S., Sukeik, M., Sarda, P., et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. J. Bone Joint Surg. 96-B:8 (2014), 1005–1015.
9. [9] Huang, Z., Ma, J., Shen, B., Pei, F., Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J. Arthroplast. 29:12 (2014), 2342–2346.
10. [10] Wang, H., Shen, B., Zeng, Y., Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 21:6 (2014), 987–993.
11. [11] Huang, Z., Ma, J., Pei, F., et al. Meta-analysis of temporary versus no clamping in TKA. Orthopedics 36:7 (2013), 543–550.
12. [12] Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, 2009, b2700.
13. [13] Keyhani, S., Esmailiejah, A.A., Abbasian, M.R., Safdari, F., Which route of tranexamic acid administration is more effective to reduce blood loss following total knee arthroplasty?. Arch Bone Jt Surg. 4:1 (2016), 65–69.
14. [14] Öztaş, S., Öztürk, A., Akalin, Y., et al. The effect of local and systemic application of tranexamic acid on the amount of blood loss and allogeneic blood transfusion after total knee replacement. Acta Orthop. Belg. 81:4 (2015), 698–707.
15. [15] Aguilera, X., Martínez-Zapata, M.J., Hinarejos, P., et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch. Orthop. Trauma Surg. 135:7 (2015), 1017–1025.
16. [16] Maniar, R.N., Kumar, G., Singhi, T., et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin. Orthop. Relat. Res. 470:9 (2012), 2605–2612.
17. [17] Digas, G., Koutsogiannis, I., Meletiadis, G., et al. Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur. J. Orthop. Surg. Traumatol. 25:7 (2015), 1181–1188.
18. [18] Gomez-Barrena, E., Ortega-Andreu, M., Padilla-Eguiluz, N.G., et al. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J. Bone Joint Surg. Am. 96:23 (2014), 1937–1944.
19. [19] Uğurlu, M., Aksekili, M.A., Çağlar, C., et al. Effect of topical and intravenously applied tranexamic acid compared to control group on bleeding in primary unilateral total knee arthroplasty. J. Knee Surg., 2, 2016 May (Epub ahead of print).
20. [20] Patel, J.N., Spanyer, J.M., Smith, L.S., et al. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J. Arthroplast. 29:8 (2014), 1528–1531.
21. [21] Soni, A., Saini, R., Gulati, A., et al. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J. Arthroplast. 29:8 (2014), 1525–1527.
22. [22] Sarzaeem, M.M., Razi, M., Kazemian, G., Moghaddam, M.E., et al. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J. Arthroplast. 29:8 (2014), 1521–1524.
23. [23] Tzatzairis, T.K., Drosos, G.I., Kotsios, S.E., et al. Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study. J. Arthroplast. 31:11 (2016), 2465–2470.
24. [24] May, J.H., Rieser, G.R., Williams, C.G., et al. The assessment of blood loss during total knee arthroplasty when comparing intravenous vs intracapsular administration of tranexamic acid. J. Arthroplast. 31:11 (2016), 2452–2457.
25. [25] Aggarwal, A.K., Singh, N., Sudesh, P., Topical vs intravenous tranexamic acid in reducing blood loss after bilateral total knee arthroplasty: a prospective study. J. Arthroplast. 31:7 (2016), 1442–1448.
26. [26] Drosos, G.I., Ververidis, A., Valkanis, C., et al. A randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement. J. Orthop. 13:3 (2016), 127–131.
27. [27] Chen, J.Y., Chin, P.L., Moo, I.H., et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee 23:1 (2016), 152–156.
28. [28] Seo, J.G., Moon, Y.W., Park, S.H., et al. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg. Sports Traumatol. Arthrosc. 21:8 (2013), 1869–1874.
29. [29] Çavuşoğlu, A.T1., Ayanoğlu, T., Esen, E., et al. Is intraarticular administration of tranexamic acid efficient and safe as systemic administration in total knee arthroplasty? Single center, randomized, controlled trial. Eklem Hastalik. Cerrahisi 26:3 (2015), 164–167.
30. [30] Goyal, N., Chen, D.B., Harris, I.A., et al. Intravenous vs intra-articular tranexamic acid in total knee arthroplasty: a randomized. Double-Blind Trial. J Arthroplasty. 32:1 (2017), 28–32.
31. [31] Zhang, Y., Zhang, L., Ma, X., et al. What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty?. Orthopade 45:7 (2016), 616–621.
32. [32] Xie, J., Ma, J., Yue, C., et al. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int. 26:1 (2016), 36–42.
33. [33] Wei, W., Wei, B., Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J. Arthroplast. 29:11 (2014), 2113–2116.
34. [34] North, W.T., Mehran, N., Davis, J.J., et al. Topical vs intravenous tranexamic acid in primary total hip arthroplasty: a double-blind. Randomized Controlled Trial. J Arthroplasty. 31:5 (2016), 1022–1026.
35. [35] Poeran, J., Rasul, R., Suzuki, S., et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 349, 2014, g4829.
36. [36] Alshryda, S., Sukeik, M., Sarda, P., et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 96-B:8 (2014), 1005–1015.
37. [37] Krohn, C.D., Sørensen, R., Lange, J.E., Riise, R., Bjørnsen, S., Brosstad, F., Tranexamic acid given into the wound reduces postoperatve blood loss by half in major orthopaedic surgery. Eur. J. Surg. Suppl. 588:588 (2003), 57–61.
38. [38] Chareancholvanich, K., Siriwattanasakul, P., Narkbunnam, R., Pornrattanamaneewong, C., Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskelet. Disord., 13(124), 2012.
39. [39] Good, L., Peterson, E., Lisander, B., Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br. J. Anaesth. 90:5 (2003), 596–599.
40. [40] Zhou, Q., Zhou, Y., Wu, H., et al. Changes of hemoglobin and hematocrit in elderly patients receiving lower joint arthroplasty without allogeneic blood transfusion. Chin. Med. J. 128:1 (2015), 75–78.
41. [41] Huang, Z.Y., Pei, F.X., Ma, J., et al. Comparison of three different tourniquet application strategies for minimally invasive total knee arthroplasty: a prospective non-randomized clinical trial. Arch. Orthop. Trauma Surg. 134:4 (2014), 561–570.
42. [42] Godier, A., Roberts, I., Hunt, B.J., Tranexamic acid: less bleeding and less thrombosis?. Crit. Care, 16(3), 2012, 135.
43. [43] Shemshaki, H., Nourian, S.M., Nourian, N., et al. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch. Orthop. Trauma Surg. 135:4 (2015), 573–588.
44. [44] Tang, H., Du, H., Tang, Q., et al. Chinese patients' satisfaction with total hip arthroplasty: what is important and dissatisfactory?. J. Arthroplast. 29:12 (2014), 2245–2250.
45. [45] Zhang, S., Xu, B., Huang, Q., et al. Early removal of drainage tube after fast-track primary total knee arthroplasty. J. Knee Surg., 24, 2016 Oct (Epub ahead of print).
46. [46] Shin, Y.S., Yoon, J.R., Lee, H.N., Park, S.H., Lee, D.H., Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg. Sports Traumatol. Arthrosc., 14, 2016 Jul (Epub ahead of print).
47. [47] Li, J., Zhang, Z., Chen, J., Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: a meta-analysis. Medicine (Baltimore), 95(36), 2016, e4689.